These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 30606718

  • 1. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
    Wu Z, Li TY, Jiang M, Yu L, Zhao J, Wang H, Zhang X, Chen W, Qiao Y.
    Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
    [Abstract] [Full Text] [Related]

  • 2. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
    Wu Z, Yu L, Lei X, Qin Y, Zhang X, Chen W, Qiao Y.
    J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
    [Abstract] [Full Text] [Related]

  • 3. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
    Zhang Q, Dong L, Hu S, Feng R, Zhang X, Pan Q, Ma J, Zhang L, Zhao X, Sankaranarayanan R, Qiao Y, Zhao F.
    Int J Cancer; 2017 Sep 15; 141(6):1110-1119. PubMed ID: 28560716
    [Abstract] [Full Text] [Related]

  • 4. Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer.
    Ferrera A, Valladares W, Cabrera Y, de la Luz Hernandez M, Darragh T, Baena A, Almonte M, Herrero R.
    Int J Cancer; 2019 Oct 15; 145(8):2042-2050. PubMed ID: 30684396
    [Abstract] [Full Text] [Related]

  • 5. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
    Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M.
    Gynecol Oncol; 2007 Sep 15; 106(3):549-57. PubMed ID: 17568661
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
    Dong L, Zhang L, Hu SY, Feng RM, Zhao XL, Zhang Q, Pan QJ, Zhang X, Qiao YL, Zhao FH.
    Clin Epigenetics; 2020 May 07; 12(1):62. PubMed ID: 32381054
    [Abstract] [Full Text] [Related]

  • 7. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ.
    Cancer Med; 2018 Nov 07; 7(11):5655-5664. PubMed ID: 30353680
    [Abstract] [Full Text] [Related]

  • 8. Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.
    Ara R, Khatun S, Pervin S, Jahan M, Shahera U, Ferdous J, Begum SA, Fatema S, Begum M, Nazneen S, Goodman A.
    Gynecol Oncol; 2020 Sep 07; 158(3):590-596. PubMed ID: 32680634
    [Abstract] [Full Text] [Related]

  • 9. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.
    Sellors JW, Schweizer JG, Lu PS, Liu B, Weigl BH, Cui JF, Peck RB, Lewis K, Lim J, Howard M, Mahoney CW, McAllister L, Berard-Bergery M, Bry C, Labiad YA, Li H, Liu L, Silver J, Chen W, Qiao YL.
    J Low Genit Tract Dis; 2011 Apr 07; 15(2):169-76. PubMed ID: 21478701
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1072-9. PubMed ID: 16030305
    [Abstract] [Full Text] [Related]

  • 12. Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
    Abedin S, Paul SK, Haque N, Ahmed S, Nasreen SA, Akhter N, Haque N, Sarkar SR, Roy S, Nahar F, Ahmed MU, Switzer J, Kobayashi N, Hossain MA, Chowdhury UW.
    Mymensingh Med J; 2019 Jan 20; 28(1):31-36. PubMed ID: 30755547
    [Abstract] [Full Text] [Related]

  • 13. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
    Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sällström J, Wilander E.
    Br J Cancer; 2000 Aug 20; 83(3):307-10. PubMed ID: 10917543
    [Abstract] [Full Text] [Related]

  • 14. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
    Omran OM, AlSheeha M.
    Pathol Oncol Res; 2015 Jan 20; 21(1):157-66. PubMed ID: 24925218
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.
    Mol Diagn; 2004 Jan 20; 8(1):57-64. PubMed ID: 15230643
    [Abstract] [Full Text] [Related]

  • 16. Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay.
    Oliveira CM, Musselwhite LW, de Paula Pantano N, Vazquez FL, Smith JS, Schweizer J, Belmares M, Possati-Resende JC, Vieira MA, Longatto-Filho A, Fregnani JHTG.
    PLoS One; 2020 Jan 20; 15(4):e0232105. PubMed ID: 32320451
    [Abstract] [Full Text] [Related]

  • 17. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
    Combes JD, Pawlita M, Waterboer T, Hammouda D, Rajkumar T, Vanhems P, Snijders P, Herrero R, Franceschi S, Clifford G.
    Int J Cancer; 2014 Nov 15; 135(10):2453-61. PubMed ID: 24729277
    [Abstract] [Full Text] [Related]

  • 18. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.
    J Clin Virol; 2012 May 15; 54(1):61-5. PubMed ID: 22326759
    [Abstract] [Full Text] [Related]

  • 19. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q, Song R, Zhao C, Liu H, Yang Y, Gu S, Feng D, He J.
    Int J Cancer; 2019 Apr 01; 144(7):1619-1632. PubMed ID: 30230542
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
    Boulet GA, Benoy IH, Depuydt CE, Horvath CA, Aerts M, Hens N, Vereecken AJ, Bogers JJ.
    Cancer Epidemiol Biomarkers Prev; 2009 Nov 01; 18(11):2992-9. PubMed ID: 19861526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.